ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs to Treat Urea Cycle Disorders Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27A15472
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drugs to Treat Urea Cycle Disorders Market Research Report 2023
BUY CHAPTERS

Global Drugs to Treat Urea Cycle Disorders Market Research Report 2025

Code: QYRE-Auto-27A15472
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Horizon Therapeutics plc
Bausch Health Companies Inc.
Nestle S A
Danone
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Aeglea Biotherapeutics, Inc
Arcturus Therapeutics Holdings Inc.
Orpharma
Selecta Biosciences Inc
Abbott
Mead Johnson & Company, LLC
Recordati Rare Diseases Inc.

Drugs to Treat Urea Cycle Disorders Market

The global market for Drugs to Treat Urea Cycle Disorders was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drugs to Treat Urea Cycle Disorders is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drugs to Treat Urea Cycle Disorders is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drugs to Treat Urea Cycle Disorders in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drugs to Treat Urea Cycle Disorders include Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Urea Cycle Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Urea Cycle Disorders.
The Drugs to Treat Urea Cycle Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs to Treat Urea Cycle Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs to Treat Urea Cycle Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drugs to Treat Urea Cycle Disorders Market Report

Report Metric Details
Report Name Drugs to Treat Urea Cycle Disorders Market
Segment by Type
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drugs to Treat Urea Cycle Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs to Treat Urea Cycle Disorders Market report?

Ans: The main players in the Drugs to Treat Urea Cycle Disorders Market are Horizon Therapeutics Plc, Bausch Health Companies Inc., Recordati Rare Diseases Inc., Nestle S.A., Danone S.A., Lucane Pharma SA, Acer Therapeutics Inc., Ultragenyx Pharmaceutical, Aeglea Biotherapeutics, Inc, Arcturus Therapeutics Holdings Inc., Orpharma Pty Ltd., Selecta Biosciences, Inc., Abbott, Mead Johnson & Company, LLC

What are the Application segmentation covered in the Drugs to Treat Urea Cycle Disorders Market report?

Ans: The Applications covered in the Drugs to Treat Urea Cycle Disorders Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Drugs to Treat Urea Cycle Disorders Market report?

Ans: The Types covered in the Drugs to Treat Urea Cycle Disorders Market report are Oral Drugs, Injection of Drugs

Recommended Reports

Rare Disease Drugs

Renal & Urinary Markets

Metabolic Disorder Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Drugs
1.2.3 Injection of Drugs
1.3 Market by Application
1.3.1 Global Drugs to Treat Urea Cycle Disorders Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs to Treat Urea Cycle Disorders Market Perspective (2020-2031)
2.2 Global Drugs to Treat Urea Cycle Disorders Growth Trends by Region
2.2.1 Global Drugs to Treat Urea Cycle Disorders Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs to Treat Urea Cycle Disorders Historic Market Size by Region (2020-2025)
2.2.3 Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Region (2026-2031)
2.3 Drugs to Treat Urea Cycle Disorders Market Dynamics
2.3.1 Drugs to Treat Urea Cycle Disorders Industry Trends
2.3.2 Drugs to Treat Urea Cycle Disorders Market Drivers
2.3.3 Drugs to Treat Urea Cycle Disorders Market Challenges
2.3.4 Drugs to Treat Urea Cycle Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs to Treat Urea Cycle Disorders Players by Revenue
3.1.1 Global Top Drugs to Treat Urea Cycle Disorders Players by Revenue (2020-2025)
3.1.2 Global Drugs to Treat Urea Cycle Disorders Revenue Market Share by Players (2020-2025)
3.2 Global Drugs to Treat Urea Cycle Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs to Treat Urea Cycle Disorders Revenue
3.4 Global Drugs to Treat Urea Cycle Disorders Market Concentration Ratio
3.4.1 Global Drugs to Treat Urea Cycle Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Urea Cycle Disorders Revenue in 2024
3.5 Global Key Players of Drugs to Treat Urea Cycle Disorders Head office and Area Served
3.6 Global Key Players of Drugs to Treat Urea Cycle Disorders, Product and Application
3.7 Global Key Players of Drugs to Treat Urea Cycle Disorders, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs to Treat Urea Cycle Disorders Breakdown Data by Type
4.1 Global Drugs to Treat Urea Cycle Disorders Historic Market Size by Type (2020-2025)
4.2 Global Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Type (2026-2031)
5 Drugs to Treat Urea Cycle Disorders Breakdown Data by Application
5.1 Global Drugs to Treat Urea Cycle Disorders Historic Market Size by Application (2020-2025)
5.2 Global Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs to Treat Urea Cycle Disorders Market Size (2020-2031)
6.2 North America Drugs to Treat Urea Cycle Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025)
6.4 North America Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs to Treat Urea Cycle Disorders Market Size (2020-2031)
7.2 Europe Drugs to Treat Urea Cycle Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025)
7.4 Europe Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size (2020-2031)
8.2 Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs to Treat Urea Cycle Disorders Market Size (2020-2031)
9.2 Latin America Drugs to Treat Urea Cycle Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025)
9.4 Latin America Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size (2020-2031)
10.2 Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Therapeutics Plc
11.1.1 Horizon Therapeutics Plc Company Details
11.1.2 Horizon Therapeutics Plc Business Overview
11.1.3 Horizon Therapeutics Plc Drugs to Treat Urea Cycle Disorders Introduction
11.1.4 Horizon Therapeutics Plc Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.1.5 Horizon Therapeutics Plc Recent Development
11.2 Bausch Health Companies Inc.
11.2.1 Bausch Health Companies Inc. Company Details
11.2.2 Bausch Health Companies Inc. Business Overview
11.2.3 Bausch Health Companies Inc. Drugs to Treat Urea Cycle Disorders Introduction
11.2.4 Bausch Health Companies Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.2.5 Bausch Health Companies Inc. Recent Development
11.3 Recordati Rare Diseases Inc.
11.3.1 Recordati Rare Diseases Inc. Company Details
11.3.2 Recordati Rare Diseases Inc. Business Overview
11.3.3 Recordati Rare Diseases Inc. Drugs to Treat Urea Cycle Disorders Introduction
11.3.4 Recordati Rare Diseases Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.3.5 Recordati Rare Diseases Inc. Recent Development
11.4 Nestle S.A.
11.4.1 Nestle S.A. Company Details
11.4.2 Nestle S.A. Business Overview
11.4.3 Nestle S.A. Drugs to Treat Urea Cycle Disorders Introduction
11.4.4 Nestle S.A. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.4.5 Nestle S.A. Recent Development
11.5 Danone S.A.
11.5.1 Danone S.A. Company Details
11.5.2 Danone S.A. Business Overview
11.5.3 Danone S.A. Drugs to Treat Urea Cycle Disorders Introduction
11.5.4 Danone S.A. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.5.5 Danone S.A. Recent Development
11.6 Lucane Pharma SA
11.6.1 Lucane Pharma SA Company Details
11.6.2 Lucane Pharma SA Business Overview
11.6.3 Lucane Pharma SA Drugs to Treat Urea Cycle Disorders Introduction
11.6.4 Lucane Pharma SA Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.6.5 Lucane Pharma SA Recent Development
11.7 Acer Therapeutics Inc.
11.7.1 Acer Therapeutics Inc. Company Details
11.7.2 Acer Therapeutics Inc. Business Overview
11.7.3 Acer Therapeutics Inc. Drugs to Treat Urea Cycle Disorders Introduction
11.7.4 Acer Therapeutics Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.7.5 Acer Therapeutics Inc. Recent Development
11.8 Ultragenyx Pharmaceutical
11.8.1 Ultragenyx Pharmaceutical Company Details
11.8.2 Ultragenyx Pharmaceutical Business Overview
11.8.3 Ultragenyx Pharmaceutical Drugs to Treat Urea Cycle Disorders Introduction
11.8.4 Ultragenyx Pharmaceutical Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.8.5 Ultragenyx Pharmaceutical Recent Development
11.9 Aeglea Biotherapeutics, Inc
11.9.1 Aeglea Biotherapeutics, Inc Company Details
11.9.2 Aeglea Biotherapeutics, Inc Business Overview
11.9.3 Aeglea Biotherapeutics, Inc Drugs to Treat Urea Cycle Disorders Introduction
11.9.4 Aeglea Biotherapeutics, Inc Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.9.5 Aeglea Biotherapeutics, Inc Recent Development
11.10 Arcturus Therapeutics Holdings Inc.
11.10.1 Arcturus Therapeutics Holdings Inc. Company Details
11.10.2 Arcturus Therapeutics Holdings Inc. Business Overview
11.10.3 Arcturus Therapeutics Holdings Inc. Drugs to Treat Urea Cycle Disorders Introduction
11.10.4 Arcturus Therapeutics Holdings Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.10.5 Arcturus Therapeutics Holdings Inc. Recent Development
11.11 Orpharma Pty Ltd.
11.11.1 Orpharma Pty Ltd. Company Details
11.11.2 Orpharma Pty Ltd. Business Overview
11.11.3 Orpharma Pty Ltd. Drugs to Treat Urea Cycle Disorders Introduction
11.11.4 Orpharma Pty Ltd. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.11.5 Orpharma Pty Ltd. Recent Development
11.12 Selecta Biosciences, Inc.
11.12.1 Selecta Biosciences, Inc. Company Details
11.12.2 Selecta Biosciences, Inc. Business Overview
11.12.3 Selecta Biosciences, Inc. Drugs to Treat Urea Cycle Disorders Introduction
11.12.4 Selecta Biosciences, Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.12.5 Selecta Biosciences, Inc. Recent Development
11.13 Abbott
11.13.1 Abbott Company Details
11.13.2 Abbott Business Overview
11.13.3 Abbott Drugs to Treat Urea Cycle Disorders Introduction
11.13.4 Abbott Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.13.5 Abbott Recent Development
11.14 Mead Johnson & Company, LLC
11.14.1 Mead Johnson & Company, LLC Company Details
11.14.2 Mead Johnson & Company, LLC Business Overview
11.14.3 Mead Johnson & Company, LLC Drugs to Treat Urea Cycle Disorders Introduction
11.14.4 Mead Johnson & Company, LLC Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
11.14.5 Mead Johnson & Company, LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Horizon Therapeutics plc
Bausch Health Companies Inc.
Nestle S A
Danone
Lucane Pharma SA
Acer Therapeutics Inc.
Ultragenyx Pharmaceutical
Aeglea Biotherapeutics, Inc
Arcturus Therapeutics Holdings Inc.
Orpharma
Selecta Biosciences Inc
Abbott
Mead Johnson & Company, LLC
Recordati Rare Diseases Inc.
List of Tables
 Table 1. Global Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral Drugs
 Table 3. Key Players of Injection of Drugs
 Table 4. Global Drugs to Treat Urea Cycle Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Drugs to Treat Urea Cycle Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Drugs to Treat Urea Cycle Disorders Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Drugs to Treat Urea Cycle Disorders Market Share by Region (2020-2025)
 Table 8. Global Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Drugs to Treat Urea Cycle Disorders Market Share by Region (2026-2031)
 Table 10. Drugs to Treat Urea Cycle Disorders Market Trends
 Table 11. Drugs to Treat Urea Cycle Disorders Market Drivers
 Table 12. Drugs to Treat Urea Cycle Disorders Market Challenges
 Table 13. Drugs to Treat Urea Cycle Disorders Market Restraints
 Table 14. Global Drugs to Treat Urea Cycle Disorders Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Drugs to Treat Urea Cycle Disorders Market Share by Players (2020-2025)
 Table 16. Global Top Drugs to Treat Urea Cycle Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Urea Cycle Disorders as of 2024)
 Table 17. Ranking of Global Top Drugs to Treat Urea Cycle Disorders Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Drugs to Treat Urea Cycle Disorders Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Drugs to Treat Urea Cycle Disorders, Headquarters and Area Served
 Table 20. Global Key Players of Drugs to Treat Urea Cycle Disorders, Product and Application
 Table 21. Global Key Players of Drugs to Treat Urea Cycle Disorders, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drugs to Treat Urea Cycle Disorders Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Drugs to Treat Urea Cycle Disorders Revenue Market Share by Type (2020-2025)
 Table 25. Global Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Drugs to Treat Urea Cycle Disorders Revenue Market Share by Type (2026-2031)
 Table 27. Global Drugs to Treat Urea Cycle Disorders Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Drugs to Treat Urea Cycle Disorders Revenue Market Share by Application (2020-2025)
 Table 29. Global Drugs to Treat Urea Cycle Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Drugs to Treat Urea Cycle Disorders Revenue Market Share by Application (2026-2031)
 Table 31. North America Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Horizon Therapeutics Plc Company Details
 Table 47. Horizon Therapeutics Plc Business Overview
 Table 48. Horizon Therapeutics Plc Drugs to Treat Urea Cycle Disorders Product
 Table 49. Horizon Therapeutics Plc Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 50. Horizon Therapeutics Plc Recent Development
 Table 51. Bausch Health Companies Inc. Company Details
 Table 52. Bausch Health Companies Inc. Business Overview
 Table 53. Bausch Health Companies Inc. Drugs to Treat Urea Cycle Disorders Product
 Table 54. Bausch Health Companies Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 55. Bausch Health Companies Inc. Recent Development
 Table 56. Recordati Rare Diseases Inc. Company Details
 Table 57. Recordati Rare Diseases Inc. Business Overview
 Table 58. Recordati Rare Diseases Inc. Drugs to Treat Urea Cycle Disorders Product
 Table 59. Recordati Rare Diseases Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 60. Recordati Rare Diseases Inc. Recent Development
 Table 61. Nestle S.A. Company Details
 Table 62. Nestle S.A. Business Overview
 Table 63. Nestle S.A. Drugs to Treat Urea Cycle Disorders Product
 Table 64. Nestle S.A. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 65. Nestle S.A. Recent Development
 Table 66. Danone S.A. Company Details
 Table 67. Danone S.A. Business Overview
 Table 68. Danone S.A. Drugs to Treat Urea Cycle Disorders Product
 Table 69. Danone S.A. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 70. Danone S.A. Recent Development
 Table 71. Lucane Pharma SA Company Details
 Table 72. Lucane Pharma SA Business Overview
 Table 73. Lucane Pharma SA Drugs to Treat Urea Cycle Disorders Product
 Table 74. Lucane Pharma SA Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 75. Lucane Pharma SA Recent Development
 Table 76. Acer Therapeutics Inc. Company Details
 Table 77. Acer Therapeutics Inc. Business Overview
 Table 78. Acer Therapeutics Inc. Drugs to Treat Urea Cycle Disorders Product
 Table 79. Acer Therapeutics Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 80. Acer Therapeutics Inc. Recent Development
 Table 81. Ultragenyx Pharmaceutical Company Details
 Table 82. Ultragenyx Pharmaceutical Business Overview
 Table 83. Ultragenyx Pharmaceutical Drugs to Treat Urea Cycle Disorders Product
 Table 84. Ultragenyx Pharmaceutical Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 85. Ultragenyx Pharmaceutical Recent Development
 Table 86. Aeglea Biotherapeutics, Inc Company Details
 Table 87. Aeglea Biotherapeutics, Inc Business Overview
 Table 88. Aeglea Biotherapeutics, Inc Drugs to Treat Urea Cycle Disorders Product
 Table 89. Aeglea Biotherapeutics, Inc Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 90. Aeglea Biotherapeutics, Inc Recent Development
 Table 91. Arcturus Therapeutics Holdings Inc. Company Details
 Table 92. Arcturus Therapeutics Holdings Inc. Business Overview
 Table 93. Arcturus Therapeutics Holdings Inc. Drugs to Treat Urea Cycle Disorders Product
 Table 94. Arcturus Therapeutics Holdings Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 95. Arcturus Therapeutics Holdings Inc. Recent Development
 Table 96. Orpharma Pty Ltd. Company Details
 Table 97. Orpharma Pty Ltd. Business Overview
 Table 98. Orpharma Pty Ltd. Drugs to Treat Urea Cycle Disorders Product
 Table 99. Orpharma Pty Ltd. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 100. Orpharma Pty Ltd. Recent Development
 Table 101. Selecta Biosciences, Inc. Company Details
 Table 102. Selecta Biosciences, Inc. Business Overview
 Table 103. Selecta Biosciences, Inc. Drugs to Treat Urea Cycle Disorders Product
 Table 104. Selecta Biosciences, Inc. Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 105. Selecta Biosciences, Inc. Recent Development
 Table 106. Abbott Company Details
 Table 107. Abbott Business Overview
 Table 108. Abbott Drugs to Treat Urea Cycle Disorders Product
 Table 109. Abbott Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 110. Abbott Recent Development
 Table 111. Mead Johnson & Company, LLC Company Details
 Table 112. Mead Johnson & Company, LLC Business Overview
 Table 113. Mead Johnson & Company, LLC Drugs to Treat Urea Cycle Disorders Product
 Table 114. Mead Johnson & Company, LLC Revenue in Drugs to Treat Urea Cycle Disorders Business (2020-2025) & (US$ Million)
 Table 115. Mead Johnson & Company, LLC Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Drugs to Treat Urea Cycle Disorders Picture
 Figure 2. Global Drugs to Treat Urea Cycle Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drugs to Treat Urea Cycle Disorders Market Share by Type: 2024 VS 2031
 Figure 4. Oral Drugs Features
 Figure 5. Injection of Drugs Features
 Figure 6. Global Drugs to Treat Urea Cycle Disorders Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drugs to Treat Urea Cycle Disorders Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Specialty Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. Drugs to Treat Urea Cycle Disorders Report Years Considered
 Figure 12. Global Drugs to Treat Urea Cycle Disorders Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Drugs to Treat Urea Cycle Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Drugs to Treat Urea Cycle Disorders Market Share by Region: 2024 VS 2031
 Figure 15. Global Drugs to Treat Urea Cycle Disorders Market Share by Players in 2024
 Figure 16. Global Top Drugs to Treat Urea Cycle Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Urea Cycle Disorders as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Drugs to Treat Urea Cycle Disorders Revenue in 2024
 Figure 18. North America Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Drugs to Treat Urea Cycle Disorders Market Share by Country (2020-2031)
 Figure 20. United States Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Drugs to Treat Urea Cycle Disorders Market Share by Country (2020-2031)
 Figure 24. Germany Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Drugs to Treat Urea Cycle Disorders Market Share by Region (2020-2031)
 Figure 32. China Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Drugs to Treat Urea Cycle Disorders Market Share by Country (2020-2031)
 Figure 40. Mexico Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Drugs to Treat Urea Cycle Disorders Market Share by Country (2020-2031)
 Figure 44. Turkey Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Drugs to Treat Urea Cycle Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Horizon Therapeutics Plc Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 48. Bausch Health Companies Inc. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 49. Recordati Rare Diseases Inc. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 50. Nestle S.A. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 51. Danone S.A. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 52. Lucane Pharma SA Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 53. Acer Therapeutics Inc. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 54. Ultragenyx Pharmaceutical Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 55. Aeglea Biotherapeutics, Inc Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 56. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 57. Orpharma Pty Ltd. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 58. Selecta Biosciences, Inc. Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 59. Abbott Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 60. Mead Johnson & Company, LLC Revenue Growth Rate in Drugs to Treat Urea Cycle Disorders Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Urea Cycle Disorders Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urea Cycle Disorders UCD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urea Solution for Vehicle Market Research Report 2025
Global Urea for Vehicle Market Research Report 2025
Global Urea Pump Market Research Report 2024
Global Industrial Urea Market Research Report 2025
Global Urea for Agriculture Market Research Report 2025
Global Urea Tank System Market Research Report 2024
Global Urea Valve Market Research Report 2025
Global Urea Tank Market Research Report 2025
Global Urea Derivatives Market Research Report 2025
Global Urea Injection Pump Market Research Report 2024
Global Coated Urea Market Research Report 2025
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global Prilled Urea Market Research Report 2024
Global Neem Coated Urea Market Research Report 2025
Global Urea Filters Market Research Report 2024
Global UREA Meter Market Research Report 2024
Global Unsymmetrically Substituted Urea Market Research Report 2025
Amino Acid Metabolism Disorder Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions